AIM
VNRX icon

Acrospire Investment Management’s VolitionRx Ltd VNRX Stock Holding History

Acrospire Investment Management’s Portfolio VNRX Stock Details VNRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-220
Closed -$20K – 2518
2016
Q4 		$20K Buy
220
+135
+159% +$12.1K 0.01% 1768
2016
Q3 		$9K Buy
+85
New +$6.6K 0.01% 1734

Other funds holding VNRX

LIM
Lagoda Investment Management New York $162M AUM 49.7% 1-Year Est. Return
SCA
Southpoint Capital Advisors New York $4.86B AUM 34.09% 1-Year Est. Return
KCM
Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
GBA
Garrison Bradford & Associates New York $92.2M AUM 19.08% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Creative Planning
Creative Planning Overland Park, Kansas $147B AUM 18.73% 1-Year Est. Return

Acrospire Investment Management's VNRX Position: Q1 2017 in Review

Acrospire Investment Management sold out of VolitionRx Ltd (VNRX) in Q1 2017, closing a stake of 220 shares — an estimated $20K sold.

Acrospire Investment Management first reported a position in VNRX in Q3 2016 and held it in 2 quarters. The position peaked at $20K in Q4 2016. 17 funds tracked by Wall St. Rank hold VNRX as of Q1 2017.

  • Acrospire Investment Management reported no remaining VolitionRx Ltd position as of Q1 2017 after selling out during the quarter.
  • Acrospire Investment Management sold 220 VolitionRx Ltd shares in Q1 2017, an estimated $20K.
  • Acrospire Investment Management first reported a position in VolitionRx Ltd in Q3 2016 and held it in 2 quarters.
  • Acrospire Investment Management's VolitionRx Ltd position peaked at $20K in Q4 2016.
  • 17 funds tracked by Wall St. Rank held VolitionRx Ltd as of Q1 2017.

Based on Acrospire Investment Management's 13F filing for Q1 2017, filed 4 May 2017.